| Julie Sacharko, APRN | |
|
41 Brewster Rd, Bristol, CT 06010-5161 | |
| (860) 585-3313 | |
| (860) 585-3500 |
| Full Name | Julie Sacharko |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 13 Years |
| Location | 41 Brewster Rd, Bristol, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063700995 | NPI | - | NPPES |
| E55652 | Other | CT | LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | E55652 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bristol Hospital | Bristol, CT | Hospital |
| Entity Name | Bristol Hospital Multi-specialty Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649265679 PECOS PAC ID: 9032014758 Enrollment ID: O20031204000960 |
News Archive
Molecular diagnostics company GenturaDx announces the completion of external HSV 1&2 alpha studies for its IDbox instrument and cassette-based tests. Conducted at an external CLIA laboratory, the study analyzed more than 130 samples, including more than 70 clinical specimens.
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced the results of a phase II clinical study showing that a short course of just four doses of its ToleroMune cat allergy therapy maintained improvements in patients' symptoms two years after the start of treatment.
The Congressional Budget Office reports the deficit is shrinking at a faster-than-expected rate this year. Medicare and Medicaid outlays are smaller than anticipated, and health care cost increases appear to have slowed. The numbers are expected to lessen the momentum to cut spending on Medicare and other entitlement programs.
At a press conference featuring healthcare leaders from throughout the state, Governor Donald L. Carcieri will announce that Rhode Island has launched a new system for tracking swine flu. Unprecedented in its approach, the system makes use of prescribing data provided by pharmacies throughout the state via a secure electronic link. In yet another first for the state and the nation, Rhode Island will also announce that it has now connected 100 percent of its retail pharmacies for e-prescribing.
› Verified 6 days ago
| Entity Name | Starling Physicians, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467537290 PECOS PAC ID: 7517863749 Enrollment ID: O20031209000877 |
News Archive
Molecular diagnostics company GenturaDx announces the completion of external HSV 1&2 alpha studies for its IDbox instrument and cassette-based tests. Conducted at an external CLIA laboratory, the study analyzed more than 130 samples, including more than 70 clinical specimens.
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced the results of a phase II clinical study showing that a short course of just four doses of its ToleroMune cat allergy therapy maintained improvements in patients' symptoms two years after the start of treatment.
The Congressional Budget Office reports the deficit is shrinking at a faster-than-expected rate this year. Medicare and Medicaid outlays are smaller than anticipated, and health care cost increases appear to have slowed. The numbers are expected to lessen the momentum to cut spending on Medicare and other entitlement programs.
At a press conference featuring healthcare leaders from throughout the state, Governor Donald L. Carcieri will announce that Rhode Island has launched a new system for tracking swine flu. Unprecedented in its approach, the system makes use of prescribing data provided by pharmacies throughout the state via a secure electronic link. In yet another first for the state and the nation, Rhode Island will also announce that it has now connected 100 percent of its retail pharmacies for e-prescribing.
› Verified 6 days ago
| Entity Name | Practitioner Support Services Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114115706 PECOS PAC ID: 3375596984 Enrollment ID: O20050223000656 |
News Archive
Molecular diagnostics company GenturaDx announces the completion of external HSV 1&2 alpha studies for its IDbox instrument and cassette-based tests. Conducted at an external CLIA laboratory, the study analyzed more than 130 samples, including more than 70 clinical specimens.
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced the results of a phase II clinical study showing that a short course of just four doses of its ToleroMune cat allergy therapy maintained improvements in patients' symptoms two years after the start of treatment.
The Congressional Budget Office reports the deficit is shrinking at a faster-than-expected rate this year. Medicare and Medicaid outlays are smaller than anticipated, and health care cost increases appear to have slowed. The numbers are expected to lessen the momentum to cut spending on Medicare and other entitlement programs.
At a press conference featuring healthcare leaders from throughout the state, Governor Donald L. Carcieri will announce that Rhode Island has launched a new system for tracking swine flu. Unprecedented in its approach, the system makes use of prescribing data provided by pharmacies throughout the state via a secure electronic link. In yet another first for the state and the nation, Rhode Island will also announce that it has now connected 100 percent of its retail pharmacies for e-prescribing.
› Verified 6 days ago
| Entity Name | Ipc Hospitalists Of New England Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821401761 PECOS PAC ID: 7618051442 Enrollment ID: O20091221000423 |
News Archive
Molecular diagnostics company GenturaDx announces the completion of external HSV 1&2 alpha studies for its IDbox instrument and cassette-based tests. Conducted at an external CLIA laboratory, the study analyzed more than 130 samples, including more than 70 clinical specimens.
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced the results of a phase II clinical study showing that a short course of just four doses of its ToleroMune cat allergy therapy maintained improvements in patients' symptoms two years after the start of treatment.
The Congressional Budget Office reports the deficit is shrinking at a faster-than-expected rate this year. Medicare and Medicaid outlays are smaller than anticipated, and health care cost increases appear to have slowed. The numbers are expected to lessen the momentum to cut spending on Medicare and other entitlement programs.
At a press conference featuring healthcare leaders from throughout the state, Governor Donald L. Carcieri will announce that Rhode Island has launched a new system for tracking swine flu. Unprecedented in its approach, the system makes use of prescribing data provided by pharmacies throughout the state via a secure electronic link. In yet another first for the state and the nation, Rhode Island will also announce that it has now connected 100 percent of its retail pharmacies for e-prescribing.
› Verified 6 days ago
| Entity Name | Hospital Medicine Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093758781 PECOS PAC ID: 9234156985 Enrollment ID: O20170802002619 |
News Archive
Molecular diagnostics company GenturaDx announces the completion of external HSV 1&2 alpha studies for its IDbox instrument and cassette-based tests. Conducted at an external CLIA laboratory, the study analyzed more than 130 samples, including more than 70 clinical specimens.
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced the results of a phase II clinical study showing that a short course of just four doses of its ToleroMune cat allergy therapy maintained improvements in patients' symptoms two years after the start of treatment.
The Congressional Budget Office reports the deficit is shrinking at a faster-than-expected rate this year. Medicare and Medicaid outlays are smaller than anticipated, and health care cost increases appear to have slowed. The numbers are expected to lessen the momentum to cut spending on Medicare and other entitlement programs.
At a press conference featuring healthcare leaders from throughout the state, Governor Donald L. Carcieri will announce that Rhode Island has launched a new system for tracking swine flu. Unprecedented in its approach, the system makes use of prescribing data provided by pharmacies throughout the state via a secure electronic link. In yet another first for the state and the nation, Rhode Island will also announce that it has now connected 100 percent of its retail pharmacies for e-prescribing.
› Verified 6 days ago
| Entity Name | Julie Sacharko Aprn Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134825094 PECOS PAC ID: 6103299193 Enrollment ID: O20230222000168 |
News Archive
Molecular diagnostics company GenturaDx announces the completion of external HSV 1&2 alpha studies for its IDbox instrument and cassette-based tests. Conducted at an external CLIA laboratory, the study analyzed more than 130 samples, including more than 70 clinical specimens.
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced the results of a phase II clinical study showing that a short course of just four doses of its ToleroMune cat allergy therapy maintained improvements in patients' symptoms two years after the start of treatment.
The Congressional Budget Office reports the deficit is shrinking at a faster-than-expected rate this year. Medicare and Medicaid outlays are smaller than anticipated, and health care cost increases appear to have slowed. The numbers are expected to lessen the momentum to cut spending on Medicare and other entitlement programs.
At a press conference featuring healthcare leaders from throughout the state, Governor Donald L. Carcieri will announce that Rhode Island has launched a new system for tracking swine flu. Unprecedented in its approach, the system makes use of prescribing data provided by pharmacies throughout the state via a secure electronic link. In yet another first for the state and the nation, Rhode Island will also announce that it has now connected 100 percent of its retail pharmacies for e-prescribing.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Julie Sacharko, APRN 41 Brewster Rd, Bristol, CT 06010-5161 Ph: (860) 585-3313 | Julie Sacharko, APRN 41 Brewster Rd, Bristol, CT 06010-5161 Ph: (860) 585-3313 |
News Archive
Molecular diagnostics company GenturaDx announces the completion of external HSV 1&2 alpha studies for its IDbox instrument and cassette-based tests. Conducted at an external CLIA laboratory, the study analyzed more than 130 samples, including more than 70 clinical specimens.
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced the results of a phase II clinical study showing that a short course of just four doses of its ToleroMune cat allergy therapy maintained improvements in patients' symptoms two years after the start of treatment.
The Congressional Budget Office reports the deficit is shrinking at a faster-than-expected rate this year. Medicare and Medicaid outlays are smaller than anticipated, and health care cost increases appear to have slowed. The numbers are expected to lessen the momentum to cut spending on Medicare and other entitlement programs.
At a press conference featuring healthcare leaders from throughout the state, Governor Donald L. Carcieri will announce that Rhode Island has launched a new system for tracking swine flu. Unprecedented in its approach, the system makes use of prescribing data provided by pharmacies throughout the state via a secure electronic link. In yet another first for the state and the nation, Rhode Island will also announce that it has now connected 100 percent of its retail pharmacies for e-prescribing.
› Verified 6 days ago
Jennifer Lauren Hohman, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 839 Farmington Ave, Bristol, CT 06010 Phone: 816-786-0582 | |
Miss Danielle Grillo, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 61 Bradley St, Suite 1, Bristol, CT 06010 Phone: 860-314-6898 | |
Christie Lee Vardhami, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 420 N Main St, Bristol, CT 06010 Phone: 860-583-5858 | |
Lynne M Whitney, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 25 Newell Rd Ste E36, Bristol, CT 06010 Phone: 860-583-9252 Fax: 860-585-9848 | |
Margaret E Weir, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 102 North St, Bristol, CT 06010 Phone: 860-314-2082 Fax: 860-314-8133 | |
Holly Fitzgerald, DNP, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 625 Clark Ave, Bristol, CT 06010 Phone: 860-583-7700 |